We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our
Privacy Policy
.
Yes, I accept
Menu
Corporate Members
E-Library
Twitter
Linked In
Facebook
Instagram
Join
MyESTRO
Search Opener
Search for:
About ESTRO
Membership
School
Workshops
Congresses
Science
Education
Advocacy
Corporate Members
E-Library
Home
Congresses
ESTRO 2026
Programme
Urological cancers 3
15 May 2026 - 19 May 2026
Stockholm, Sweden
ESTRO 2026
Session
Sunday
May 17
10:30 - 11:30
K2
Urological cancers 3
Co-Chair:
Ioan Flavius Coser
,
Romania
;
Chair:
Stefano Maria Magrini
,
Italy
Session Type:
Poster Discussions
Track:
Clinical
Journey:
Add to
My Programme
10:30 - 11:30
Three-fractions Linac-Based Prostate SBRT Using 4D Transperineal Ultrasound Monitoring: Preliminary Clinical Outcomes and Analysis of Motion Patterns
Presenter
:
Federica Ferrario
,
Italy
Presentation Number:
-233
10:30 - 11:30
Post-treatment ADC predicts long-term outcomes after definitive radiotherapy for prostate cancer with or without focal boost
Presenter
:
Cem Onal
,
Turkey
Presentation Number:
-468
10:30 - 11:30
Safety of Elective Pelvic Nodal Irradiation in High-Risk Post-Prostatectomy Patients: A Subgroup Analysis from POPART (PELVART) Cohort
Presenter
:
Federica Ferrario
,
Italy
Presentation Number:
-1142
10:30 - 11:30
Phase 1 Study of Localized Antiandrogen Therapy Using Biolen® (Bicalutamide) Implants with Radiotherapy for Localized Prostate Cancer
Presenter
:
Deborah Citrin
,
USA
Presentation Number:
-4509
10:30 - 11:30
Patient- and Clinician-Reported adverse events in primary Prostate Only and Whole Pelvis Moderately Hypofractionated Prostate Radiotherapy
Presenter
:
Leo Andexlinger
,
Austria
Presentation Number:
-589
10:30 - 11:30
Reirradiation of local recurrences of prostate cancer: PROSTARE (PROstate cancer STereotActic REirradiation) early safety analysis of a phase 2 study
Presenter
:
Wojciech Majewski
,
Poland
Presentation Number:
-1850
10:30 - 11:30
Predictive value of the circulating T-cell receptor repertoire in oligorecurrent prostate cancer treated with SBRT: results from a prospective trial
Presenter
:
Fabio Matrone
,
Italy
Presentation Number:
-2331
10:30 - 11:30
Prognostic Factors for Recurrence and Survival in Bladder-Preserving Therapy for Muscle-Invasive Bladder Cancer
Presenter
:
Felipe Couñago Lorenzo
,
Spain
Presentation Number:
-2078
10:30 - 11:30
Impact of Medical Operability For Primary Renal Cell Carcinoma After Stereotactic Ablative Radiotherapy
Presenter
:
Vivian Tan
,
Canada
Presentation Number:
-1690
10:30 - 11:30
Definitive Radiotherapy for Stage T4 Non-Metastatic Prostate Cancer: Long-Term Outcomes from a multicentric collaboration
Presenter
:
Vasanthapriya Subramani
,
India
Presentation Number:
-2338
E-Mail Address
Please enter a user name
Password
Cancel
Forgotten Password
Create MyESTRO Account
i
Please log in to add this session to your programme.